• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

anonymous

Guest
Does anyone have experience with ADA accommodations either for yourself or someone you know well that you could share. Field pharma reps with any sort of mental impairment (cognitive fx, Anxiety, MDD, ADD, Panic or anything similar)? If so what types of accommodations were made and was the rep able to succeed with them? This really is a serious question, please don't bash. Genuinely need examples of other reps experiences.